Amgen Execs to Present at Goldman Sachs Healthcare Conference
Event summary
- Amgen will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026.
- Peter Griffith (CFO) and Murdo Gordon (EVP of Global Markets and Policy) will lead the presentation.
- The webcast will be available live and archived for at least 90 days on Amgen's website.
- Amgen focuses on innovative medicines for cancer, inflammatory conditions, rare diseases, heart disease, and obesity.
The big picture
Amgen's participation in the Goldman Sachs Healthcare Conference underscores its strategic focus on innovation and market expansion. As a key player in the biotechnology sector, Amgen's presentation will likely highlight its pipeline advancements and regulatory strategies, which are critical for maintaining its competitive edge in treating complex diseases. The event provides a platform for Amgen to communicate its long-term growth prospects to investors and analysts.
What we're watching
- Pipeline Progress
- How Amgen's pipeline advancements in cancer and inflammatory conditions will impact its market position.
- Regulatory Dynamics
- Whether Amgen can navigate regulatory hurdles for its obesity-related treatments.
- Market Strategy
- The pace at which Amgen can sustain its innovation leadership in the biotech sector.
Related topics